news Tool to track SARS-CoV-2 mutations could inform drug development 11 September 2020 | By Victoria Rees (Drug Target Review) A new tool called COVID-3D that monitors SARS-CoV-2 genome mutations could aid drug and vaccine development, its creators say.
news Engineered protein could be used to treat type 2 diabetes 3 September 2020 | By Victoria Rees (Drug Target Review) An engineered form of the SMOC1 protein has shown success as a type 2 diabetes treatment in animal models, say researchers.
news Adding RPL6 protein to vaccine prevents malaria in mice, find researchers 18 May 2020 | By Victoria Rees (Drug Target Review) Researchers have shown that adding the RPL6 protein to malaria vaccines was successful at protecting mice against the condition.
news Process that immune cells use to detect infections and cancers discovered 10 January 2020 | By Rachael Harper (Drug Target Review) Researchers have discovered how gamma-delta T cells become activated which could lead to the development of new and improved immunotherapy treatments.
news Strep A vaccine target identified for global use 30 May 2019 | By Victoria Rees (Drug Target Review) Researchers use high-throughput DNA sequencing technology to identify a potential vaccine target for Strep A.